Epidemiology of invasive pneumococcal disease in the Arabian Peninsula and Egypt

International Journal of Antimicrobial Agents

Volumn 33, Issue 5, 2009, Pages 410.e1-410.e9

  Shibl, Atef ^a   Memish, Ziad ^b   Pelton, Stephen ^c  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING FAHAD NATIONAL GUARD HOSPITAL   (Saudi Arabia)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Invasive; Pneumococcus; Surveillance; Vaccine

Indexed keywords

AMPICILLIN; CEFOTAXIME; CEPHALOSPORIN; ERYTHROMYCIN; HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE; OXACILLIN; PNEUMOCOCCUS VACCINE; UNCLASSIFIED DRUG;

BACTEREMIA; BACTERIUM ISOLATE; CHILDHOOD DISEASE; EGYPT; EPIDEMIC; FATALITY; HIGH RISK POPULATION; HUMAN; IMMUNIZATION; INCIDENCE; INFECTION PREVENTION; KUWAIT; MORBIDITY; MORTALITY; NONHUMAN; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTION; PNEUMOCOCCAL MENINGITIS; PRIORITY JOURNAL; QATAR; SAUDI ARABIA; SEROTYPE; SHORT SURVEY; STREPTOCOCCUS PNEUMONIAE; UNITED ARAB EMIRATES; YEMEN;

EID: 62949213759     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.08.012     Document Type: Short Survey

References (41)

1. Pneumococcal conjugate vaccine for childhood immunization-WHO position paper. Wkly Epidemiol Rec 2007;82:93-104.
2. Arai S., Konda T., Wad A., Matsunaga Y., Okabe N., Watanabe H., et al. Use of antiserum-coated latex particles for serotyping Streptococcus pneumoniae. Microbiol Immunol 45 (2001) 159-162
3. Shouval D.S., Greenberg D., Givon-Lavi N., Porat N., and Dagan R. Site-specific disease of individual Streptococcus pneumoniae serotypes in pediatric invasive disease, acute otitis media and acute conjunctivitis. Pediatr Infect Dis J 25 (2006) 602-607
4. Whitney C.G., Farley M.M., Hadler J., Harrison L.H., Lexau C., Reingold A., et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med 343 (2000) 1917-1924
5. Twum-Danso K., Al-Mazrou A.M., Kambal A.M., and Al-Zamil F.A. Penicillin resistance in serogroups/serotypes of Streptococcus pneumoniae causing invasive infections in Central Saudi Arabia. Saudi Med J 24 (2003) 1210-1213
6. Al-Mazrou A., Twum-Danso K., Al Zamil F., and Kambal A. Streptococcus pneumoniae serotypes/serogroups causing invasive disease in Riyadh, Saudi Arabia: extent of coverage by pneumococcal vaccines. Ann Saudi Med 25 (2005) 94-99
7. Memish Z.A., Balkhy H.H., Shibl A.M., Barrozo C.P., and Gray G.C. Streptococcus pneumoniae in Saudi Arabia: antibiotic resistance and serotypes of recent clinical isolates. Int J Antimicrob Agents 23 (2004) 32-38
8. Kambal A.M., and Abdullah A.M. Childhood pneumococcal bacteraemia in Riyadh, Saudi Arabia. Ann Trop Paediatr 17 (1997) 245-251
9. Almuneef M., Alshaalan M., Memish Z., and Alaola S. Bacterial meningitis in Saudi Arabia: the impact of Haemophilus influenzae type b vaccination. J Chemother 13 (2001) 34-39
10. Al-Tawfiq J.A. Antibiotic resistance of pediatric isolates of Streptococcus pneumoniae in a Saudi Arabian hospital from 1999 to 2004. Med Sci Monit 12 (2006) CR471-CR475
11. Al-Mazrou Y.Y., Al-Jeffri M.H., Al-Haggar S.H., Musa E.K., Mohamed O.M., and Abdalla M.N. Haemophilus type B meningitis in Saudi children under 5 years old. J Trop Pediatr 50 (2004) 131-136
12. Almuneef M., Memish Z., Khan Y., Kagallwala A., and Alshaalan M. Childhood bacterial meningitis in Saudi Arabia. J Infect 36 (1998) 157-160
13. Shibl A.M. Distribution of serotypes and antibiotic resistance of invasive pneumococcal disease isolates among children less than five years old in Saudi Arabia (2000-2004). Clin Microbiol Infect 14 (2008) 876-879
14. Memish Z., Al-Otaibi B., Al Shaalan M., Alola S., and Althaqafi A.H. A retrospective epidemiological study of invasive pneumococcal disease in children aged 0-5 years in the Kingdom of Saudi Arabia. Proceedings of the 6th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD). June 8-12, 2008, Reykjavik, Iceland (2008) [Abstract no. 130]
15. Youssef F.G., El-Sakka H., Azab A., Eloun S., Chapman G.D., Ismail T., et al. Etiology, antimicrobial susceptibility profiles, and mortality associated with bacterial meningitis among children in Egypt. Ann Epidemiol 14 (2004) 44-48
16. Farag H.M., Abdel-Fattah M.M., and Youssri A.M. Epidemiological, clinical and prognostic profile of acute bacterial meningitis among children in Alexandria, Egypt. Indian J Med Microbiol 23 (2005) 95-101
17. Wasfy M.O., Pimentel G., Abdel-Maksoud M., Russell K.L., Barrozo C.P., Klena J.D., et al. Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae causing meningitis in Egypt, 1998-2003. J Antimicrob Chemother 55 (2005) 958-964
18. Dash N., Ameen A.S., Sheek-Hussein M.M., and Smego R.A. Epidemiology of meningitis in Al-Ain, United Arab Emirates, 2000-2005. Int J Infect Dis 11 (2007) 309-312
19. Mahmoud R., Mahoud M., Badrinath P., Sheek-Hussein M., Alwash R., and Nicol A.G. Pattern of meningitis in Al-Ain Medical District, United Arab Emirates-a decadal experience (1990-99). J Infect 44 (2002) 22-25
20. Elsaid M.F., Flamerzi A.A., Bessisso M.S., and Elshafie S.S. Acute bacterial meningitis in Qatar. Saudi Med J 27 (2006) 204-210
21. Husain E.E., Al-Shawaf F., Bahbahani E., El-Nabi M.H., Al-Fotooh K.A., Shafiq M.H., et al. Epidemiology of childhood meningitis in Kuwait. Med Sci Monit 13 (2007) CR220-CR223
22. Zaki M., Daoud A.S., ElSaleh Q., and West P.W.J. Childhood bacterial meningitis in Kuwait. J Trop Med Hyg 93 (1990) 7-11
23. Mokaddas E.M., Rotimi V.O., and Albert M.J. Implications of Streptococcus pneumoniae penicillin resistance and serotype distribution in Kuwait for disease treatment and prevention. Clin Vaccine Immunol 15 (2008) 203-207
24. Khorasani A.A., and Banajeh S. Bacterial profile and clinical outcome of childhood meningitis in rural Yemen: a 2-year hospital-based study. J Infect 53 (2006) 228-234
25. Hausdorff W.P., et al., Middle East & North Africa Vaccine-Preventable Diseases Regional Advisory Group. The epidemiology of pneumococcal, meningococcal, and Haemophilus disease in the Middle East and North Africa (MENA) region-current status and needs. Vaccine 25 (2007) 1935-1944
26. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 3rd ed. Approved standard. Document M7-A3. Villanova, PA: NCCLS; 1993.
27. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. 9th ed. Approved standard. Document M100-S9. Wayne, PA: NCCLS; 1999. p. 23-6.
28. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 6th ed. Approved standard. Document M7-A6. Wayne, PA: NCCLS; 2003.
29. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disc susceptibility tests. 8th ed. Approved standard. Document M2-A8. Wayne, PA: NCCLS; 2003.
30. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Fifteenth informational supplement. Document M100-S15. Wayne, PA: CLSI; 2005. p. 126-32.
31. Ajayi-Obe E.K., Lodi E., Alkai A.S., Galbati M., Rooney C., Mannoni B., et al. Prognostic scores for use in African meningococcal epidemics. Bull World Health Organ 76 (1998) 149-152
32. World Health Organization. Pneumococcal vaccines. Immunization, vaccines and biologicals (2003), WHO, Geneva, Switzerland. http://www.who.int/vaccine/en/pneumococcus.shtml [accessed February 21, 2008]
33. Hausdorff W.P., Bryant J., Paradiso P.R., and Siber G.R. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use. Part I. Clin Infect Dis 30 (2000) 100-121
34. McIntosh E.D., Fritzell, and Fletcher M.A. Burden of paediatric invasive pneumococcal disease in Europe 2005. Epidemiol Infect 135 (2007) 644-656
35. Scott D.A., Komjathy S.F., Hu B.T., Baker S., Supan L.A., Monahan C.A., et al. Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults. Vaccine 25 (2007) 6164-6166
36. Block S., Bryant K.A., and Scott D.A. Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine. Proceedings of the Pediatric Academic Societies' Annual Meeting. 5-8 May 2007, Toronto, Canada (2007) [Abstract 5735.2]
37. Klugman K.P. Pneumococcal resistance to antibiotics. Clin Microbiol Rev 3 (1990) 171-196
38. Fletcher M.A., Laufer D.S., McIntosh E.D., Cimino C., and Malinoski F.J. Controlling invasive pneumococcal disease: is vaccination of at-risk groups sufficient?. Int J Clin Pract 60 (2006) 450-456
39. Vergison A., et al., Belgian Invasive Pneumococcal Disease Study Group. Epidemiologic features of invasive pneumococcal disease in Belgian children: passive surveillance is not enough. Pediatrics 118 (2006) e801-e809
40. Eskola J., Kilpi T., Palmu A., Jokinen J., Haapakoski J., Herva E., et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 344 (2001) 403-409
41. Kalin M. Pneumococcal serotypes and their clinical relevance. Thorax 53 (1998) 159-162